As a member of Hyperion’s corporate management team, Dr. Kalns provides strategic direction and contributes to the company’s research and development pursuits. He has a Ph.D. in Pharmaceutics and has led scientific support work for government customers for over 15 years. Dr. Kalns’ entrepreneurial spirit is a driving force in Hyperion’s ability to provide new services to government customers. His passion for discovery has contributed to important research and development solutions for commercial applications.
Current role
Corporate VP, Chief Scientific Officer at Integra LifeSciences
Executive VP, Chief Scientific Officer at Transgene
VP & Chief Scientific Officer at PIC Therapeutics
VP, Chief Scientific Officer - China at Sirnaomics
VP, Chief Scientific Officer & Director, The Saban Research Institute at Children's Hospital Los Angeles